University of Calgary — Calgary, Alberta

Public research footprint of University of Calgary, compiled from the ClinicalTrials.gov public registry.

997

Registered studies

255

Active

140

Recruiting now

505

Completed

146

Stopped or withdrawn

Most-studied conditions

Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) · Fascioscapulohumeral Muscular Dystrophy Type 1 · Tourette Syndrome in Children · ADHD Predominantly Inattentive Type

Recently updated registry entries

NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)
NCT06014424 — Cannabidiol Medication Intervention Trial (Recruiting)
NCT03435796 — Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Calgary?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.